TITLE:
A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

CONDITION:
Pancreatic Cancer

INTERVENTION:
Gemcitabine

SUMMARY:

      The purpose of this study is to determine the effectiveness and side effects of LY293111
      given in combination with gemcitabine in patients with pancreatic cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Adenocarcinoma of the pancreas that is locally advanced or metastatic and not
             amenable to resection with curative intent

          -  Tumor that can be measured by x-ray or scan

          -  Adequate organ function

        Exclusion Criteria:

          -  Inability to swallow capsules

          -  Documented brain metastases

          -  Prior chemotherapy or biological therapy for this disease
      
